ERCP in patients over 90 years old: Safety and efficacy comparison with a younger cohort

Abstract

Background and study aims As life expectancy increases worldwide, so does the prevalence of biliary tract and pancreatic disorders, resulting in rising demand for invasive procedures such as endoscopic retrograde cholangiopancreatography (ERCP) in the elderly. Few studies have assessed the safety of ERCP in patients 90 years and older, particularly among the Hispanic population. The primary aim of this study was to determine the technical success and adverse events (AEs) associated with ERCP in patients 90 years of age or older in comparison to a younger cohort of patients.

Patients and methods A retrospective analysis of all ERCPs done at our institution from 2012 to 2018 was performed. Three hundred ERCPs in patients < 90 years old and all 28 ERCPs done in patients ≥ 90 years old were included in the analysis.

Results ERCPs were successfully completed in 96.4% of patients > 90 years old and 96.3% of the < 90-year-old cohort (realtive risk [RR] 1.00, confidence interval 0.92-1.07). There was no difference in the rate of periprocedural AEs. Post-ERCP AEs occurred in 7.1% and 3.0% in patients aged < 90 and > 90 years, respectively (RR 2.38, 0.54-10.48). No deaths were directly attributed to the procedure; however, inpatient mortality was higher in the group aged > 90 years.

Conclusions ERCP is safe and effective in nonagenarian patients, and advanced age should not be considered an independent risk factor for AEs nor a contraindication for the procedure.

Keywords

Quality and logistical aspects - Performance and complications - ERCP - Pancreaticobiliary diseases - Biliary stones - Biliary strictures - Post-ERCP pancreatitis

Publication History

Received: 29 June 2022

Accepted after revision: 21 July 2023

Accepted Manuscript online:
14 August 2023

Article published online:
06 October 2023

• References

• 1 World Health Organization, National Institute on Aging, National Institutes of Health. NIH Publication no.11–7737. 2011
• 2 Departamento de Salud. Informe de la salud en Puerto Rico. 2016
• 3 Levit K, Smith C, Cowan C. et al. Trends in U.S. health care spending, 2001. Health Aff 2003; 22: 154-164
• 4 Kwon CI, Song SH, Hahm KB. et al. Unusual complications related to endoscopic retrograde cholangiopancreatography and its endoscopic treatment. Clin Endosc 2013; 46: 251-259 DOI: 10.5946/ce.2013.46.3.251. (PMID: 23767036)
• 5 Freeman ML, Nelson DB, Sherman S. et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-918 DOI: 10.1056/NEJM199609263351301. (PMID: 8782497)
• 6 Wang P, Li ZS, Liu F. et al. Risk factors for ERCP-related adverse events: a prospective multicenter study. Am J Gastroenterol 2009; 104: 31-40
• 7 Williams EJ, Taylor S, Fairclough P. et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39: 793-801 DOI: 10.1055/s-2007-966723. (PMID: 17703388)
• 8 Andriulli A, Loperfido S, Napolitano G. et al. Incidence rates of post-ERCP adverse events: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-1788
• 9 Chandrasekhara V, Khashab MA, Muthusamy VR. et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
• 10 Cotton PB, Lehman G, Vennes J. et al. Endoscopic sphincterotomy adverse events and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-393
• 11 Wada K, Takada T, Kawarada Y. et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007; 14: 52-55 DOI: 10.1007/s00534-006-1156-7. (PMID: 17252297)
• 12 Siegel HJ, Kasmin FE. Biliary tract diseases in the elderly: management and outcomes. Gut 1997; 41: 433-435 DOI: 10.1136/gut.41.4.433. (PMID: 9391238)
• 13 Clarke GA, Jacobson BC, Hammett RJ. et al. The indications, utilization and safety of gastrointestinal endoscopy in an extremely elderly patient cohort. Endoscopy 2001; 33: 580-584 DOI: 10.1055/s-2001-15313. (PMID: 11473328)
• 14 Murata A, Motomura Y, Akahoshi K. et al. Therapeutic ERCP for choledocholithiasis in patients 80 years of age and older. J Clin Gastroenterol 2009; 43: 289-290 DOI: 10.1097/MCG.0b013e318165dc94. (PMID: 18978507)
• 15 Sobani ZA, Yunina D, Abbasi A. et al. Endoscopic retrograde cholangiopancreatography in nonagenarian patients: Is it really safe?. Clin Endosc 2018; 51: 375-380
• 16 Day LW, Lin L, Somsouk M. Adverse events in older patients undergoing ERCP: a systematic review and meta-analysis. Endosc Int Open 2014; 2: E28-E36 DOI: 10.1055/s-0034-1365281. (PMID: 26134610)
• 17 Finkelmeier F, Tal A, Ajouaou M. et al. ERCP in elderly patients: increased risk of sedation adverse events but low frequency of post-ERCP pancreatitis. Gastrointest Endosc 2015; 82: 1051-1059 DOI: 10.1016/j.gie.2015.04.032. (PMID: 26089104)